Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Permethrin toxicity is still a cause of poisoning in cats
A campaign is underway to ensure owners understand the dangers of using permethrin products on cats 

International Cat Care is undertaking a campaign following recent reported incidents of cat-death after use of permethrin-containing dog flea products. This is the most common cause of cat poisoning in many countries, simply because permethrin-containing products are widely and easily available.
The campaign is demanding that dog spot-on flea products containing permethrin should not be issued without a verbal warning at the point of sale. Although packaging states that it is not safe for use on cats, this is either being overlooked or not taken seriously.
When a customer buys a permethrin-containing product it should also be checked whether there are cats in the home where it will be used. It should be warned that after treatment, dogs and cats must be kept separate for 72 hours.
There are other non-permethrin-containing products sold in pet shops under the NFA-VPS authorisation, and many of these have a much safer profile if used accidentally on cats.
Dr Andy Sparkes, Veterinary Director of International Cat Care commented “Many practices see permethrin poisoning in cats several times a year but do not contact the Veterinary Medicines Directorate (VMD) because the product is not a Prescription Only Medication (POM), or they feel that the Directorate is already aware of the problem. We feel strongly that the problem is greatly under-reported. Nothing will be done unless the full extent of the problem is realised by the VMD, so please report each one by going to http://www/vmd.defra.gov.uk/adversereactionreporting/".

 

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.